These results collectively confirm that SIK2 enhances CRC cell survival from IR by promoting cell proliferation and inhibiting IR‐induced apoptosis, thereby contributing to radioresistance in both in vitro and in vivo models. This evidence concerns the gene SIK2 and colorectal carcinoma.